HomeLTI0 • FRA
add
Aptose Biosciences Inc
Previous close
€1.47
Day range
€1.48 - €1.48
Year range
€1.34 - €4.05
Market cap
4.29M USD
Avg Volume
29.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.46M | -44.05% |
Net income | -5.54M | 42.50% |
Net profit margin | — | — |
Earnings per share | -2.61 | 88.08% |
EBITDA | -5.46M | 43.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.74M | -49.15% |
Total assets | 7.47M | -41.65% |
Total liabilities | 14.86M | 17.39% |
Total equity | -7.39M | — |
Shares outstanding | 2.55M | — |
Price to book | -0.51 | — |
Return on assets | -155.19% | — |
Return on capital | -347.88% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.54M | 42.50% |
Cash from operations | -2.80M | 76.24% |
Cash from investing | — | — |
Cash from financing | 829.00K | -93.00% |
Net change in cash | -1.96M | -3.04% |
Free cash flow | -204.62K | 97.49% |
About
Founded
1986
Headquarters
Website
Employees
13
